IP Library › Granted Patent US 10,028,924
Granted Patent B2
US 10,028,924 · App. 15/031,036 · Granted Jul 24, 2018

Antimicrobial compositions

Inventors: Sarah Leibowitz (Kansas City, MO); N. Camelia Traistaru (Kansas City, MO)
Assignee: DeLaval Holding AB
A61K31/19A01N37/36A61K9/0041A61K47/10A61K47/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,028,924
App. No.
15/031,036
Granted
Jul 24, 2018
Kind
B2
Abstract

Antimicrobial compositions and related methods are disclosed. The antimicrobial compositions include glycolic acid, an anionic surfactant, and at least one additional surfactant selected from anionic and nonionic surfactants.

Claims (22)

1. An antimicrobial composition comprising:

glycolic acid as the only organic acid present in said composition;

sodium octane sulfonate or sodium lauryl sulfate;

a C9-C11 alcohol ethoxylate surfactant; and

at least one additional anionic surfactant, wherein said at least one additional anionic surfactant comprises a C14-C16 alpha-olefin sulfonate, and

wherein said composition is characterized by a Lysis/Denaturation (L/D) ratio greater than 100.

2. The composition according to claim 1 , wherein the glycolic acid, sodium octane sulfonate or sodium lauryl sulfate, and the additional anionic surfactant are each present in an amount ranging from about 0.01 to 40 wt. %.

3. A method for controlling or preventing bovine mastitis comprising contacting the teats of a cow with a teat dip that comprises:

glycolic acid as the only organic acid present in said composition;

sodium octane sulfonate or sodium lauryl sulfate;

a C9-C11 alcohol ethoxylate surfactant; and

at least one additional anionic surfactant, wherein said at least one additional anionic surfactant comprises a C14-C16 alpha-olefin sulfonate,

wherein said teat dip is characterized by a Lysis/Denaturation (L/D) ratio greater than 100.

4. The method according to claim 3 , wherein the glycolic acid, sodium octane sulfonate or sodium lauryl sulfate, and the additional anionic surfactant are each present in an amount ranging from about 0.01 to 40 wt. %.

5. The composition according to claim 1 , wherein the composition comprises from 0.5% to 10% by weight of glycolic acid.

6. The composition according to claim 1 , wherein the composition comprises from 0.25% to 5% by weight of the sodium octane sulfonate or sodium lauryl sulfate.

7. The composition according to claim 1 , wherein the composition comprises from 0.05% to 2% by weight of the C14-C16 alpha-olefin sulfonate.

8. The composition according to claim 1 , wherein the composition comprises from 0.05% to 1% by weight of the C9-C11 alcohol ethoxylate surfactant.

9. The method according to claim 3 , wherein the teat dip comprises from 0.5% to 10% by weight of glycolic acid.

10. The method according to claim 3 , wherein the teat dip comprises from 0.25% to 5% by weight of the sodium octane sulfonate or sodium lauryl sulfate.

11. The method according to claim 3 , wherein the teat dip comprises from 0.05% to 2% by weight of the C14-C16 alpha-olefin sulfonate.

12. The method according to claim 3 , wherein the teat dip comprises from 0.05% to 1% by weight of the C9-C11 alcohol ethoxylate surfactant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2016
From: LIEBOWITZ, SARAH; TRAISTARU, N. CAMELIA
To: DELAVAL HOLDING AB
Reel/Frame 038342/0025 →
Continuity (2)
Provisional Application 61895232 · Oct 24, 2013
Related Publication 20160263062A1 · Sep 15, 2016
Cited By (1)
US 12,329,157